Christine Nash

Christine Nash

Director/Board Member at RALLYBIO CORPORATION

Net worth: - $ as of 2026-08-30

53 year
Health Technology
Commercial Services
Consumer Services

Profile

Ms. Christine A. Nash is an Independent Director at Rallybio Corp.
She is on the Board of Directors at Rallybio Corp.
Ms. Nash was previously employed as a Principal by Chatiemac Consulting LLC, a Chief Commercial Officer & Senior Vice President by Hyperion Therapeutics, Inc., a Marketing Director by CoTherix, Inc., a Principal by Eli Lilly & Co., a Product Manager by Genesoft Pharmaceuticals, Inc., a Principal by Imana, Inc., and a Principal by Oncology Therapeutics Network Corp.
She also served on the board at CM Group LLC.
She received her undergraduate degree from Stanford University and an MBA from Stanford University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-12-18 0 ( -.--% ) - $ 2026-08-30

Christine Nash active positions

CompaniesPositionStart
RALLYBIO CORPORATION Director/Board Member 2022-04-03

Former positions of Christine Nash

CompaniesPositionEnd
Director/Board Member 2022-08-31
HYPERION THERAPEUTICS INC Corporate Officer/Principal 2015-04-30
Sales & Marketing 2007-01-31
Chatiemac Consulting LLC
Corporate Officer/Principal -
Imana, Inc.
Corporate Officer/Principal -
See the detail of Christine Nash's experience

Training of Christine Nash

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

62

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Distribution Services

Technology Services

Imana, Inc.

Health Technology

Chatiemac Consulting LLC

  1. Stock Market
  2. Insiders
  3. Christine Nash